Annual Report FY26: Revenue up 19%, consolidated loss narrows sharply

Going-concern doubtNet loss reportedEBITDA margin expansionExceptional itemResults View source PDF Explain this filing

HEALTHX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹290.50

prior close

₹296.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+3.1% vs market

Healthcare Service Provider peers, median of 28sector-0.4%+4.2% vs sector

On the reaction day the stock moved 3.1 pts more than Nifty Microcap 250 and 4.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.8+0.7+3.1-0.4+4.2

Next day

+2.0+1.1+0.9-0.5+2.5

+4.1+1.6+2.5-0.4+4.5

+4.3+1.5+2.8-0.7+5.0

+5.0+1.3+3.7-1.1+6.1

+5.7+1.4+4.3-1.0+6.7

+3.3-2.1+5.3-1.8+5.1

15d

-1.4-0.9-0.5-3.3+1.9

-3.6-1.4-2.1-5.7+2.1

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Health X Platform (formerly Sastasundar Ventures) filed FY25-26 annual report. Consolidated revenue rose to Rs 1,31,927 lakhs from Rs 1,11,095 lakhs. Consolidated EBITDA improved to Rs 615 lakhs from Rs 381 lakhs. Net loss narrowed sharply to Rs 145 lakhs from Rs 13,354 lakhs. Standalone continues to post losses. Board approved a composite restructuring scheme involving demerger into Microsec Resources and amalgamation of subsidiaries. No dividend recommended. Subsidiary Genu Path Labs has going concern doubt flagged by its auditors.

Likely market impact

Sharp drop in consolidated loss and revenue growth are positives. Restructuring scheme and going concern flag on a step-down subsidiary warrant close watch.